Biogen Inc. (BVMF:BIIB34)
Brazil · Delayed Price · Currency is BRL 161.80
-0.20 (-0.12%)
At close: Feb 5, 2026
Biogen Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 1,293 | 1,632 | 1,161 | 3,047 | 1,556 |
Depreciation & Amortization | 779.9 | 673.2 | 494.8 | 518.4 | 487.7 |
Loss (Gain) From Sale of Assets | - | -88.6 | - | -503.7 | - |
Asset Writedown & Restructuring Costs | 145.8 | 60.2 | - | 119.6 | 647.3 |
Loss (Gain) From Sale of Investments | 19.3 | 101.4 | 277.1 | -1,240 | 826.8 |
Loss (Gain) on Equity Investments | - | - | - | -2.6 | -34.9 |
Stock-Based Compensation | 290.8 | 291.2 | 264.2 | 254.1 | 238.6 |
Other Operating Activities | 733.5 | 361.1 | -1.3 | 81.4 | 63.8 |
Change in Accounts Receivable | 102.7 | 222.3 | 61.3 | -203.4 | 324.8 |
Change in Inventory | -64.7 | -273.8 | -130.9 | -320.2 | -462.4 |
Change in Other Net Operating Assets | -137.5 | -182.2 | -280.1 | -224.4 | -238.7 |
Operating Cash Flow | 2,205 | 2,876 | 1,547 | 1,384 | 3,640 |
Operating Cash Flow Growth | -23.33% | 85.85% | 11.77% | -61.97% | -13.95% |
Capital Expenditures | -153.8 | -153.7 | -277 | -240.3 | -258.1 |
Sale of Property, Plant & Equipment | - | - | - | 582.6 | - |
Cash Acquisitions | - | -1,075 | -6,926 | - | - |
Divestitures | - | - | - | - | 28.1 |
Sale (Purchase) of Intangibles | -31.6 | -117.5 | -34.4 | -2.9 | -36.8 |
Investment in Securities | -1,179 | 551.5 | 3,148 | 1,213 | -309.8 |
Other Investing Activities | -7.1 | -4.7 | -11.3 | 24.4 | 12.9 |
Investing Cash Flow | -1,371 | -799.2 | -4,101 | 1,577 | -563.7 |
Long-Term Debt Issued | 1,733 | - | 997.2 | - | - |
Long-Term Debt Repaid | -2,030 | -650 | -809.9 | -1,002 | -170 |
Net Debt Issued (Repaid) | -296.9 | -650 | 187.3 | -1,002 | -170 |
Repurchase of Common Stock | - | - | - | -750 | -1,800 |
Other Financing Activities | -5 | -33.5 | -38 | 4.9 | -116.2 |
Financing Cash Flow | -301.9 | -683.5 | 149.3 | -1,747 | -2,086 |
Foreign Exchange Rate Adjustments | 101.9 | -67.7 | 35.1 | -55.7 | -59.8 |
Net Cash Flow | 633.5 | 1,325 | -2,369 | 1,158 | 930.2 |
Free Cash Flow | 2,051 | 2,722 | 1,270 | 1,144 | 3,382 |
Free Cash Flow Growth | -24.65% | 114.28% | 11.03% | -66.17% | -11.12% |
Free Cash Flow Margin | 20.73% | 28.13% | 12.91% | 11.24% | 30.80% |
Free Cash Flow Per Share | 13.94 | 18.66 | 8.72 | 7.84 | 22.61 |
Cash Interest Paid | 264.1 | 245.4 | 252.2 | 262.5 | 280.8 |
Cash Income Tax Paid | 864 | 355.1 | 740.7 | 932.9 | 247.9 |
Levered Free Cash Flow | 1,982 | 3,419 | 981.44 | 1,393 | 2,208 |
Unlevered Free Cash Flow | 2,149 | 3,575 | 1,136 | 1,547 | 2,365 |
Change in Working Capital | -1,058 | -155.2 | -648.7 | -890.3 | -145.5 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.